Related Experiment Video
Updated: Sep 30, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
Peripheral arterial disease is only the tip of the atherosclerotic "iceberg"
Laurie G Futterman1, Louis Lemberg
1Department of Medicine, University of Miami School of Medicine, FL 33101, USA.
Insights
Peripheral artery disease (PAD) is underrecognized and undertreated. Early diagnosis and comprehensive management, including antiplatelet and lipid-lowering therapies, are crucial for preventing cardiovascular events in PAD patients.
Area of Science:
- Vascular Biology and Medicine
Background:
- The peripheral vascular system, the largest organ system, harbors potential for novel therapeutic targets.
- Coronary and noncoronary circulations are interconnected, necessitating a holistic approach to vascular health.
Observation:
- Peripheral artery disease (PAD) is frequently underdiagnosed and undertreated.
- Key therapies like antiplatelet and lipid-lowering treatments are underutilized in PAD patients.
- Atherosclerosis management requires addressing multifactorial issues across all arterial beds.
Findings:
- Clopidogrel, an antiplatelet agent, effectively prevents adverse cardiovascular events in individuals with PAD.
- Therapeutic angiogenesis shows promise in alleviating severe claudication symptoms.
Implications:
- Cardiologists and primary care physicians must adopt a global perspective in managing PAD.
- Improved recognition and utilization of evidence-based therapies can significantly enhance patient outcomes in PAD.
Abstract:
The peripheral vascular system makes up the largest single "organ system" and holds many biological secrets that, when unlocked, can open doors for new treatments for all vascular beds, including those of the coronary and cerebral arteries. The coronary and noncoronary circulations are inseparable and interdependent. Cardiologists as well as primary care physicians should have a global view in the management of patients with PAD. The treatment of atherosclerosis in any of the arterial beds is a multifactorial problem. PAD is underrecognized. Antiplatelet and lipid-lowering therapy is underutilized in patients with PAD. Clopidogrel, an antiplatelet drug, has proven to prevent adverse cardiovascular events in patients with PAD. Therapeutic angiogenesis has been reported to improve severe claudication.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
09:09Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis I: Introduction